Cotrimoxazole led to lower serious adverse events compared with furazolidone; GRADE not reported.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether cotrimoxazole changes other adverse events clinical criteria compared with beta‐lactams (very low certainty).
It is very uncertain whether cotrimoxazole changes other adverse events clinical criteria compared with fluoroquinolones (norfloxacin) (very low certainty).